Sunshine Biopharma Inc. (SBFM)
Nasdaq: SBFM · Pharmaceutical Preparations · Fort Lauderdale, FL · filing with the SEC since 2007
Who runs Sunshine Biopharma Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
0
of 1 people with a filing in the last fifteen months
Directors reporting now
1
10 people on the record since 2009
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Natan David | director | Feb 2022 | Aug 11, 2026 | none |
Earlier names on the record11, newest filing first
Roy Michel · officer · last filing Jan 2025Slilaty Steve N. · officer · last filing Mar 2024Beaudoin Marc · officer · last filing Feb 2024Sebaaly Camille · officer · last filing Dec 2022Chamoun Malek · 10% owner · last filing Oct 2022Keller Andrew Mark · director · last filing Feb 2022Kiderchah Rabi · director · last filing Dec 2021Kish James Daniel · director · last filing Dec 2021Telsey Andrew I · director · last filing Dec 2021Merzouki Abderrazzak · officer · last filing Feb 2021Advanomics Corp · 10% owner · last filing Nov 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.